2022.11.10
Increase R&D investment, BGI supports accurate nucleic acid detection in multiple dimensions
Since the outbreak of COVID-19, China has effectively controlled the virus with strong technology, and formulated relevant management policies in time, so that people's lives can quickly return to normal.
Since the outbreak of COVID-19, China has effectively controlled the virus with strong technology, and formulated relevant management policies in time, so that people's lives can quickly return to normal.
As the founder of China's gene industry, BGI has developed a series of COVID-19 detection products and built a fire eye nucleic acid detection laboratory based on advanced gene detection technology and a scientific research platform with advanced technology and complete configuration.
Related News
2022.09.16
We are an international company
We have Europe office in Sweden for the Sales and technical support. We have 1400㎡ GMP factory and 800㎡ R&D center in Asia. We have more than 50 employees in global.
Details
2022.11.10
Skilled in operation, but unable to understand the mechanism? These key points of nucleic acid detection need to be mastered!
With the implementation of strict control measures, the rampant epidemic of COVID-19 has been effectively curbed, and we have a gap for adjustment. In the process of nucleic acid batch screening, many colleagues are skilled in operation, but the mechanism is not very clear. Based on this, we have summarized the contents that may be involved in the detection of COVID-19 nucleic acid, with a view to helping the majority of colleagues to "know what is going on and why".
Details
